Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 5/20 | 0.41 |
| ▸ | HCRTR1 | O43613 | 6/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 6/20 | 0.41 |
| ▸ | HAAO | P46952 | 1/20 | 0.37 |
| ▸ | CMA1 | P23946 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL302594 | 0.86 | HCRTR1 (0.40) | NOTUMHCRTR1HCRTR2ALDH1A1 | |
| SCHEMBL1586907 | 0.86 | HCRTR1 (0.53) | NOTUMHCRTR1HCRTR2CMA1ALDH1A1 | |
| SCHEMBL29160361 | 0.80 | NOTUM (0.45) | NOTUMHCRTR1HCRTR2ALDH1A1 | |
| SCHEMBL9286585 | 0.80 | NOTUM (0.40) | NOTUMHCRTR1HCRTR2CMA1 | |
| SCHEMBL18016687 | 0.77 | NOTUM (0.51) | NOTUMCMA1ALDH1A1 | |
| SCHEMBL27883266 | 0.75 | HCRTR1 (0.54) | NOTUMHCRTR1HCRTR2ALDH1A1 | |
| SCHEMBL17028392 | 0.75 | NOTUM (0.41) | NOTUMHCRTR1HCRTR2ALDH1A1 | |
| SCHEMBL1670997 | 0.75 | HCRTR1 (0.53) | HCRTR1HCRTR2ALDH1A1 | |
| SCHEMBL1586336 | 0.74 | HCRTR1 (0.55) | HCRTR1HCRTR2 | |
| SCHEMBL5790843 | 0.74 | NOTUM (0.47) | NOTUMHCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1725544-A1 | 3-[4-HETEROCYCLYL-1,2,3-TRIAZOL-1-YL]-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2006-11-29 | — | — | EP | disclosed |
| WO-2005090333-A1 | 3-‘4-HETEROCYCLYL -1,2,3,-TRIAZOL-1-YL!-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2005-09-29 | — | — | WO | disclosed |